The Effect of Norepinephrine on the Development of Pressure Injury
NCT ID: NCT06860308
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
289 participants
OBSERVATIONAL
2024-12-01
2025-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aimed to examine the effect of norepinephrine infusion on the development of pressure injuries among patients in adult intensive care.
This retrospective and correlational study was conducted between March 2021- May 2022. The electronic patient data were obtained from 289 adult patients (Case group n=149; control group n=149) treated with and without norepinephrine in the intensive care unit, respectively. The demographic and clinical characteristics were evaluated using descriptive statistical methods (number, percentage, mean, standard deviation). A logistic regression model was established to estimate the dependent variable (development of pressure injury) with the independent variables.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Vasopressor on Pressure Injury Development
NCT06163352
Assessment of Automatic Relays by Intensive Basis Advantage Compared With Manual Relays, on the Hypotension Risks, During Noradrenalin Administration
NCT01127152
NORepinephrine-Maintaining-individuaALIZEd Blood Pressure
NCT03715712
Control Mean Arterial Pressure in the Intensive Care Unit
NCT04639037
Comparison of Hemodynamic Results of Two Different Fluid Managements
NCT05733403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case Group
Patients with norepinephrine infusion in the intensive care unit,
No interventions assigned to this group
Control group
Patients without norepinephrine in the intensive care unit
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years old
* who did not have pressure injuries upon admission to the intensive care unit. Patients who received norepinephrine and received norepinephrine infusion for at least 48 hours during their stay in ICU were included in the case group (n=149), and patients who did not receive an infusion were included in the control group (n=140).
Exclusion Criteria
* less than 18
* who have pressure injuries during admission
* who had norepinephrine infusion less than48 hours during their stay in the intensive care unit.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Koç University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayda Kebapci
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Koç University Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NR24022025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.